The TGF‐βpathway genes (THBS1 and SMAD2) report on epithelial–mesenchymal transition and immunosuppressive signaling, while Th2‐associated markers (CCR4, GATA3) indicate a helper T‐cell polarization state that favors tumor progression. Here, SMAD2 is linked to neoplasm.